Kristin Wynholds

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Leslie Miller, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kristin Wynholds:

Company Role Class Num Shares Value Price $ Report Date Ownership
Better Therapeutics, Inc. Chief Product Officer Common Stock 225,631 $38,335 $0.1699 18 Dec 2023 Direct
Better Therapeutics, Inc. Chief Product Officer Stock Option (Right to Buy) 101,450 01 Mar 2023 Direct

Insider Reports Filed by Kristin Wynholds

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000095017023071959-wynholds-kristin-2023-12-18 Better Therapeutics, Inc. 18 Dec 2023 1 $0 4 Chief Product Officer 20 Dec 2023, 17:23
/report/000095017023013897-wynholds-kristin-2023-03-01 Better Therapeutics, Inc. 01 Mar 2023 2 $0 4 Chief Product Officer 21 Apr 2023, 18:13
/report/000089924322037418-wynholds-kristin-2022-05-31 Better Therapeutics, Inc. 31 May 2022 2 +$12,420 4 Chief Product Officer 02 Dec 2022, 15:15
/report/000089924322013366-wynholds-kristin-2022-04-01 Better Therapeutics, Inc. 01 Apr 2022 1 $0 4 Chief Product Officer 04 Apr 2022, 16:45
/report/000089924321042231-wynholds-kristin-2021-10-28 Better Therapeutics, Inc. 28 Oct 2021 0 $0 3 Chief Product Officer 01 Nov 2021, 20:30